Updated: Lilly’s Statement on the CMMI BALANCE Model for GLP-1 Medicines and Medicare GLP-1 Bridge Model
Today, the Centers for Medicare and Medicaid Services issued new implementation details for the Medicare and Medicaid CMMI BALANCE Model, marking a significant milestone in delivering on the commitment Lilly made with the U.S. government to expand access to our obesity medicines and lower costs for
